Animalcare Group Plc (ANCR) Ordinary 20p

Sell:240.00pBuy:246.00p4.00p (1.62%)

Prices delayed by at least 15 minutes
Sell:240.00p
Buy:246.00p
Change:4.00p (1.62%)
Prices delayed by at least 15 minutes
Sell:240.00p
Buy:246.00p
Change:4.00p (1.62%)
Prices delayed by at least 15 minutes

Company Information

About this company

Animalcare Group plc is a United Kingdom-based international veterinary sales and marketing company. The Company is focused on bringing products to market through its own development pipeline, partnerships and through acquisitions. The Company develops and commercializes prescription and over-the-counter pharmaceutical products that improve animal health and wellbeing. These are developed in-house, acquired from other companies or in-licensed from its partners. The Company manages an international supply chain, including specialist veterinary wholesalers and distributors. It partners with companies to commercialize products across Europe. The Company operates in three categories within the veterinary market: companion animals, equine and other, and production animals. Its product pipeline is Daxocox, which is a differentiated COX-2 inhibitor for the treatment of chronic pain in dogs. The Company operates in seven countries and exports to about 40 countries in Europe and worldwide.

Key people

Jennifer Ann Julia Winter
Chief Executive Officer, Executive Director
Chris J. Brewster
Chief Financial Officer, Executive Director, Company Secretary
Edwin Torr
Independent Non-Executive Chairman of the Board
Marc Coucke
Non-Executive Director
Douglas Eugene Hutchens
Independent Non-Executive Director
Sylvia Metayer
Senior Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    ANCR
  • Location
    United Kingdom
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    GB0032350695
  • Market cap
    £167.63m
  • Employees
    226
  • Shares in issue
    68.98m
  • Exchange
    London Stock Exchange (LON)
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.